Amgen, Adaptive Partner In COVID-19 Neutralizing Antibody R&D Effort

 
• By Joseph Haas
SC2004_Research Team_1039502866_1200.jpg
Amgen and Adaptive are combining their expertise to seek a neutralizing antibody fight COVID-19

More from COVID-19

More from Scrip